newsfilter
← Latest News
GlobeNewswire·

Sema4 to Participate at Two Investor Conferences in June 2022

STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following investor conferences: Conference: